Hyperaldosteronism screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Hyperaldosteronism}} | {{Hyperaldosteronism}} | ||
{{CMG}}; '''Assistant Editor-in-Chief:''' [[User:Soumya Sachdeva|Soumya Sachdeva]] | |||
==Overview== | |||
Screening for hyperaldosteronism is done by measuring the aldosterone-renin ratio(ARR) on current blood pressure medication (stop spironolactone for 4 weeks) and with hypokalemia corrected (ARR screen positive if ARR>750 pmol/l:ng/ml/h and aldosterone>450 pmol/l)<ref>Harrison's Principles of Internal Medicine</ref> | |||
Screening for hyperaldosteronism is done by measuring the aldosterone-renin ratio(ARR) on current blood pressure medication(stop spironolactone for 4 weeks) and with hypokalemia corrected (ARR screen positive if ARR>750 pmol/l:ng/ml/h and aldosterone>450 pmol/l)<ref>Harrison's Principles of Internal Medicine</ref> | |||
Revision as of 16:04, 10 May 2014
|
Hyperaldosteronism Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor-in-Chief: Soumya Sachdeva
Overview
Screening for hyperaldosteronism is done by measuring the aldosterone-renin ratio(ARR) on current blood pressure medication (stop spironolactone for 4 weeks) and with hypokalemia corrected (ARR screen positive if ARR>750 pmol/l:ng/ml/h and aldosterone>450 pmol/l)[1]
References
- ↑ Harrison's Principles of Internal Medicine